InVivo Therapeutics Holdings Price on July 21, 2023

NVIVDelisted Stock  USD 1.38  0.07  5.34%   
If you're considering investing in InVivo Stock, it is important to understand the factors that can impact its price. As of today, the current price of InVivo Therapeutics stands at 1.38, as last reported on the 14th of December 2024, with the highest price reaching 1.40 and the lowest price hitting 1.31 during the day. We have found twenty-nine technical indicators for InVivo Therapeutics, which you can use to evaluate the volatility of the firm. Please check out InVivo Therapeutics' risk adjusted performance of 0.0214, and Market Risk Adjusted Performance of 0.0497 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
InVivo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NVIV
Based on monthly moving average InVivo Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of InVivo Therapeutics by adding InVivo Therapeutics to a well-diversified portfolio.

InVivo Therapeutics Valuation on July 21, 2023

It is possible to determine the worth of InVivo Therapeutics on a given historical date. On July 21, 2023 InVivo was worth 1.24 at the beginning of the trading date compared to the closed value of 1.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of InVivo Therapeutics stock. Still, in general, we apply an absolute valuation method to find InVivo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of InVivo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against InVivo Therapeutics' related companies.
 Open High Low Close Volume
  1.25    1.34    1.25    1.29    42,178  
07/21/2023
  1.24    1.29    1.24    1.25    8,400  
  1.31    1.40    1.31    1.38    29,132  
Backtest InVivo Therapeutics  |  InVivo Therapeutics History  |  InVivo Therapeutics Valuation   PreviousNext  
Open Value
1.24
1.25
Closing Value
1.24
Upside

InVivo Therapeutics Trading Date Momentum on July 21, 2023

On July 24 2023 InVivo Therapeutics Holdings was traded for  1.38  at the closing time. The top price for the day was 1.40  and the lowest listed price was  1.31 . The trading volume for the day was 29.1 K. The trading history from July 24, 2023 was a factor to the next trading day price increase. The trading delta at closing time against the next closing price was 10.40% . The trading delta at closing time against the current closing price is 4.80% .

InVivo Therapeutics Fundamentals Correlations and Trends

By evaluating InVivo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among InVivo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. InVivo financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About InVivo Therapeutics Stock history

InVivo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for InVivo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in InVivo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing InVivo Therapeutics stock prices may prove useful in developing a viable investing in InVivo Therapeutics
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.

InVivo Therapeutics Stock Technical Analysis

InVivo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of InVivo Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of InVivo Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

InVivo Therapeutics Period Price Range

Low
December 14, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

InVivo Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

InVivo Therapeutics December 14, 2024 Market Strength

Market strength indicators help investors to evaluate how InVivo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading InVivo Therapeutics shares will generate the highest return on investment. By undertsting and applying InVivo Therapeutics stock market strength indicators, traders can identify InVivo Therapeutics Holdings entry and exit signals to maximize returns

InVivo Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for InVivo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of InVivo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of InVivo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in InVivo Stock

If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Money Managers
Screen money managers from public funds and ETFs managed around the world